Amended Statement of Beneficial Ownership (sc 13d/a)
10 Gennaio 2023 - 11:23PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 3)*
Meridian
Bioscience, Inc.
(Name of Issuer)
Common Stock, no par value
(Title of Class of Securities)
589584101
(CUSIP Number of Class of Securities)
David J. Snyderman
Magnetar Capital LLC
1603 Orrington Ave.
Evanston, Illinois 60201
(847) 905-4400
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
January
6, 2023
(Date of Event which Requires Filing of this Statement)
If
the filing person has previously filed a Statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D
and is filing this Schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. ¨
Note: Schedules filed in paper format shall include
a signed original and five copies of the schedule, including all exhibits. See Rule 240.13d-7(b) for other parties to whom copies are
to be sent.
*The remainder of this cover page shall be filled
out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent
amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this
cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
CUSIP No. 589584101 | SCHEDULE 13D | Page 2 of 10 |
1. |
NAME
OF REPORTING PERSON:
Magnetar Financial LLC
|
2. |
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ¨
(b) x |
3. |
SEC
USE ONLY
|
4. |
SOURCE
OF FUNDS
OO
|
5. |
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) ¨
|
6. |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
NUMBER OF
SHARES |
7. |
SOLE
VOTING POWER
0 |
BENEFICIALLY
OWNED BY |
8. |
SHARED
VOTING POWER
2,204,418 |
EACH REPORTING
PERSON |
9. |
SOLE
DISPOSITIVE POWER
0 |
WITH |
10. |
SHARED
DISPOSITIVE POWER
2,204,418 |
11. |
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,204,418 |
12. |
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
13. |
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.02% |
14. |
TYPE OF REPORTING PERSON
IA; OO |
|
|
|
|
CUSIP No. 589584101 | SCHEDULE 13D | Page
3 of 10 |
1. |
NAME
OF REPORTING PERSON:
Magnetar Capital Partners LP
|
2. |
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ¨
(b) x |
3. |
SEC
USE ONLY
|
4. |
SOURCE
OF FUNDS
OO
|
5. |
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) ¨
|
6. |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
NUMBER OF
SHARES |
7. |
SOLE
VOTING POWER
0 |
BENEFICIALLY
OWNED BY |
8. |
SHARED
VOTING POWER
2,204,418 |
EACH REPORTING
PERSON |
9. |
SOLE
DISPOSITIVE POWER
0 |
WITH |
10. |
SHARED
DISPOSITIVE POWER
2,204,418 |
11. |
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,204,418 |
12. |
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
¨
|
13. |
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.02% |
14. |
TYPE OF REPORTING PERSON
HC; OO |
|
|
|
|
CUSIP No. 589584101 | SCHEDULE 13D | Page
4 of 10 |
1. |
NAME
OF REPORTING PERSON:
Supernova Management LLC
|
2. |
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ¨
(b) x |
3. |
SEC
USE ONLY
|
4. |
SOURCE
OF FUNDS
OO
|
5. |
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) ¨
|
6. |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
NUMBER OF
SHARES |
7. |
SOLE
VOTING POWER
0 |
BENEFICIALLY
OWNED BY |
8. |
SHARED
VOTING POWER
2,204,418 |
EACH REPORTING
PERSON |
9. |
SOLE
DISPOSITIVE POWER
0 |
WITH |
10. |
SHARED
DISPOSITIVE POWER
2,204,418 |
11. |
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,204,418 |
12. |
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
¨
|
13. |
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.02% |
14. |
TYPE OF REPORTING PERSON
HC; OO |
|
|
|
|
CUSIP No. 589584101 | SCHEDULE 13D | Page
5 of 10 |
1. |
NAME
OF REPORTING PERSON:
David J. Snyderman
|
2. |
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ¨
(b) x |
3. |
SEC
USE ONLY
|
4. |
SOURCE
OF FUNDS
OO
|
5. |
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) ¨
|
6. |
CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
|
NUMBER OF
SHARES |
7. |
SOLE
VOTING POWER
0 |
BENEFICIALLY
OWNED BY |
8. |
SHARED
VOTING POWER
2,204,418 |
EACH REPORTING
PERSON |
9. |
SOLE
DISPOSITIVE POWER
0 |
WITH |
10. |
SHARED
DISPOSITIVE POWER
2,204,418 |
11. |
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,204,418 |
12. |
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
¨
|
13. |
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.02% |
14. |
TYPE OF REPORTING PERSON
HC; IN |
|
|
|
|
SCHEDULE 13D
| item 1. | security and issuer |
This
Amendment No. 3 (the “Amendment No. 3”) relates to the Statement of Beneficial Ownership on Schedule 13D filed jointly
by Magnetar Financial LLC, a Delaware limited liability company (“Magnetar Financial”), Magnetar Capital Partners LP,
a Delaware limited partnership (“Magnetar Capital Partners”), Supernova Management LLC, a Delaware limited liability
company (“Supernova Management”), and David J. Snyderman with the SEC on December 2, 2022, (as amended by this Amendment
No. 2, the “Schedule 13D”).
Except as set forth below, all Items of the Schedule
13D remain unchanged. All capitalized terms not otherwise defined herein shall have the meanings ascribed to such terms in the Schedule
13D.
| ITEM 4. | PURPOSE OF TRANSACTION |
Item 4 of the Schedule 13D is hereby amended
to add the following information for updating:
Since the filing of Amendment
No. 2 on December 2, 2022, the Reporting Persons purchased 43,573 Shares between December 2, 2022 and January 9, 2023 reported herein,
which consists of 43,573 Shares purchased for the benefit of PRA Master Fund.
In addition, since the filing
of Amendment No. 2 on December 2, 2022, the Reporting Persons sold 12,449 Shares between December 2, 2022 and January 9, 2023 reported
herein, which consists of 12,449 Shares sold for the benefit of Systematic Master Fund.
| ITEM 5. | INTEREST IN SECURITIES OF THE ISSUER |
Item 5(a)-(c) of the Schedule 13D is hereby
amended to add the following information for updating:
The Company reported in their
Form 10-K filed on November 22, 2022 that 43,827,819 Shares were issued and outstanding as of October 31, 2022.
(a)
As of the close of business January 9, 2023, each of the Reporting Persons may have been deemed to have beneficial ownership of
2,204,418 Shares, which consisted of (i) 1,894,930 Shares held for the benefit of PRA Master Fund, (ii) 304,301 Shares held for the benefit
of Systematic Master Fund, and (iii) 5,187 Shares held for the benefit of the Managed Account and all such Shares represented beneficial
ownership of approximately 5.02% of the Shares.
(b)
As of the close of business January 9, 2023, each of the Reporting Persons may have been deemed to share the power to vote and
direct the disposition of 2,204,418 Shares, which consisted of (i) 1,894,930 Shares held for the benefit of PRA Master Fund, (ii) 304,301
Shares held for the benefit of Systematic Master Fund, and (iii) 5,187 Shares held for the benefit of the Managed Account and all such
and all such Shares represented beneficial ownership of approximately 5.02% of the Shares.
(c)
Except as set forth on Schedule A attached hereto and Item 6, the Funds had no transactions in the Shares during the 60
days preceding the date of filing of this Statement. All of the transactions set forth on Schedule A attached hereto were effected
in the ordinary course of business of Magnetar Financial for the accounts of each of the Funds. The transactions in the Shares set forth
on Schedule A were effected in open market transactions on the NASDAQ and various other trading markets.
SIGNATURE
After reasonable inquiry and
to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: January 10, 2023 |
|
|
|
|
|
|
magnetar
financial llc |
|
|
|
|
By:
Magnetar Capital Partners LP, its Sole Member |
|
|
|
|
By: |
/s/
David J. Snyderman |
|
|
Name: |
David
J. Snyderman |
|
|
Title: |
Manager of Supernova Management LLC, the General
Partner of Magnetar Capital Partners LP |
|
|
|
|
magnetar
capital partners LP |
|
|
|
|
By: |
/s/
David J. Snyderman |
|
|
Name: |
David J. Snyderman |
|
|
Title: |
Manager of Supernova Management LLC, the General Partner of Magnetar Capital Partners LP |
|
|
|
|
supernova
management llc |
|
|
|
|
By: |
/s/
David J. Snyderman |
|
|
Name: |
David J.
Snyderman |
|
|
Title: |
Manager |
|
|
|
|
/s/
David J. Snyderman |
|
David
J. Snyderman |
SCHEDULE A
Funds
Date | |
Number of Shares Bought | | |
Price Per Share($) (1)(2) | |
1/4/2023 | |
| 9,866 | | |
| 33.38 | (3) |
1/5/2023 | |
| 10,583 | | |
| 33.41 | (4) |
1/6/2023 | |
| 15,978 | | |
| 33.55 | (5) |
1/9/2023 | |
| 7,146 | | |
| 33.56 | (6) |
(1) Excludes commissions and
other execution-related costs.
(2) Upon request by the staff of the Securities and Exchange
Commission, full information regarding the number of shares bought or sold (as the case may be) at each separate price will be provided.
(3) Reflects a weighted average purchase price
of $33.38 per share, at prices ranging from $33.33 to $33.45 per share.
(4) Reflects a weighted average purchase price
of $33.41 per share, at prices ranging from $33.37 to $33.45 per share.
(5) Reflects a weighted average purchase price
of $33.55 per share, at prices ranging from $33.43 to $33.63 per share.
(6) Reflects a weighted average purchase price
of $33.56 per share, at prices ranging from $33.52 to $33.60 per share.
SCHEDULE A
Funds
Date | |
Number of Shares Sold | | |
Price Per Share($) (1)(2) | |
1/5/2023 | |
| 4,108 | | |
| 33.41 | (3) |
1/6/2023 | |
| 4,170 | | |
| 33.54 | (4) |
1/9/2023 | |
| 4,171 | | |
| 33.56 | (5) |
(1)Excludes commissions and
other execution-related costs.
(2) Upon request by the staff of the Securities and Exchange
Commission, full information regarding the number of shares bought or sold (as the case may be) at each separate price will be provided.
(3) Reflects a weighted average purchase price
of $33.41 per share, at prices ranging from $33.38 to $33.45 per share.
(4) Reflects a weighted average purchase price
of $33.54 per share, at prices ranging from $33.43 to $33.59 per share.
(5) Reflects a weighted average purchase price
of $33.56 per share, at prices ranging from $33.52 to $33.60 per share.
EXHIBIT INDEX
Grafico Azioni Meridian Bioscience (NASDAQ:VIVO)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Meridian Bioscience (NASDAQ:VIVO)
Storico
Da Giu 2023 a Giu 2024